Commentary: Battle of the bioprosthetic valve blood thinners

Affiliations

¹ Division of Cardiothoracic Surgery, DeWitt Daughtry Department of Surgery, University of Miami Miller School of Medicine, Miami, Fla. Electronic address: alnajarmd@gmail.com.
² Division of Biostatistics, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Fla.
³ Division of Cardiothoracic Surgery, DeWitt Daughtry Department of Surgery, University of Miami Miller School of Medicine, Miami, Fla.

Free article

Editorial

Ahmed Alnajar et al. J Thorac Cardiovasc Surg. 2023 Jan.

Free article

. 2023 Jan;165(1):69-70.

doi: 10.1016/j.jtcvs.2021.02.064. Epub 2021 Feb 22.

¹ Division of Cardiothoracic Surgery, DeWitt Daughtry Department of Surgery, University of Miami Miller School of Medicine, Miami, Fla. Electronic address: alnajarmd@gmail.com.
² Division of Biostatistics, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Fla.
³ Division of Cardiothoracic Surgery, DeWitt Daughtry Department of Surgery, University of Miami Miller School of Medicine, Miami, Fla.

No abstract available

Comment on

Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: A randomized clinical trial.
Shim CY, Seo J, Kim YJ, Lee SH, De Caterina R, Lee S, Hong GR; Explore the Efficacy and Safety of Edoxaban in Patients after Heart Valve Repair or Bioprosthetic Valve Replacement (ENAVLE) study group. Shim CY, et al. J Thorac Cardiovasc Surg. 2023 Jan;165(1):58-67.e4. doi: 10.1016/j.jtcvs.2021.01.127. Epub 2021 Feb 9. J Thorac Cardiovasc Surg. 2023. PMID: 33726903 Clinical Trial.